Skip to main content

The Vascular Renin System

  • Chapter

Part of the book series: Contemporary Endocrinology ((COE,volume 1))

Abstract

In the classical endocrine renin—angiotensin system (RAS), renin secreted from the kidney cleaves hepatic angiotensinogen in the circulation to launch a cascade of angiotensin peptides including angiotensin (A) I, II, and III. AII, the most prominent of these peptide hormones, initiates through specific plasma membrane receptors, a host of physiological actions ranging from vasoconstriction to volume and growth regulation (1-4). Circulating plasma levels of renin and/or AII do not always correlate with their purported functions (5, 6),because of inaccuracies of renin and/or AII measurements, or not considering the sodium status (7). Studies with angiotensin-converting enzyme (ACE) inhibitors, and more recently with specific AII receptor antagonists, have demonstrated that even when the circulating levels are low, AII remains a major regulator of many biological responses, including blood pressure (8).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barrett PQ, Bollag WB, Rasmussen H. Mechanism of action of angiotensin II. In: Cooke BA, King RJB, van der Molen HJ, eds. Hormones and Their Actions, Part II. Elsevier Science, Amsterdam 1988, pp. 211–229.

    Chapter  Google Scholar 

  2. Naftilan AJ, Pratt RE, Eldridge CS, Lin HC, Dzau VJ. Angiotensin II c-fos expression in smooth muscle via transcriptional control. Hypertension 1989;13:706–711.

    Article  PubMed  CAS  Google Scholar 

  3. Phillips MI, Hofman WE. Sensitive sites in the brain for the blood pressure and drinking responses to AII. In: Buckley JP, Ferrario CH, eds. Central Actions of Angiotensin and Related Hormones. Pergamon, New York, 1977, pp. 325–356.

    Google Scholar 

  4. Malvin RL, Mouw D, Vander AJ, Gregg C. Hypothalamic stimulation of ADH by angiotensin II. In: Buckley JP, Ferrario CH, eds. Central Actions of Angiotensin and Related Hormones. Pergamon, New York, 1977, pp. 257–267.

    Google Scholar 

  5. Schalekamp MA, Derkx FH, van den Meiracker AH. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system. J Hypertens Suppl 1992;10:5157-S164.

    Article  PubMed  CAS  Google Scholar 

  6. Swales JD. The renin-angiotensin system as a target for therapeutic intervention. J Cardiovas Pharm 1994;24(Suppl. 2): S1–S5.

    CAS  Google Scholar 

  7. von Lutterotti N, Catanzaro DF, Sealey JE, Laragh JH. Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation 1994;89:458–470.

    Article  PubMed  CAS  Google Scholar 

  8. McAreavey D, Robertson JI. Angiotensin converting enzyme inhibitors and moderate hypertension. Drugs 1990;40:326–345.

    Article  PubMed  CAS  Google Scholar 

  9. Kalinyak JE, Dorin RI, Hoffman AC, Perlman AJ. Tissue specific regulation of glucocorticoid receptor mRNA by dexamethasone. J Biol Chem 1987;262:460–464.

    PubMed  CAS  Google Scholar 

  10. Mizuno K, Tani M, Niimura S, Sanada H, Haga H, Hashimoto S, Watanabe H, Ohtsuki M, Fukuchi S. Losartan, a specific angiotensin II receptor antagonists, increases angiotensin and angiotensin II release from isolated rat hind legs: evidence for locally regulated renin-angiotensin system in vascular tissue. Life Sci 1992;50:209–214.

    Article  Google Scholar 

  11. Mizuno K, Niimura S, Tani M, Haga H, Inagami T, Fukuchii S. Direct proof for local generation and release of angiotensin II in peripheral human vascular tissue. Hypertension 1988;11:223–229.

    Article  PubMed  CAS  Google Scholar 

  12. Ganong WF. Origin of the angiotensin II secreted by cells. Proc Soc Exp Biol Med 1994;205:213–219.

    PubMed  CAS  Google Scholar 

  13. Mulrow PJ, Kusano E, Baba K, Shier D, Doi Y, Franco-Saenz R, Stoner G, Rapp J. Adrenal renin: a possible local hormonal regulator of aldosterone production. Cardiovasc Drugs Ther 1988;2: 463–471.

    Article  PubMed  CAS  Google Scholar 

  14. Sawa H. Angiotensinogen: gene expression and protein localization in human tissues. Hokkaido Igaku Zasshi 1990;65:189–199.

    PubMed  CAS  Google Scholar 

  15. Dostal DE, Rothblum KN, Conrad KM, Cooper GR, Baker KM. Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am J Physiol 1992;263:C851–C863.

    PubMed  CAS  Google Scholar 

  16. Dzau VJ. Molecular and physiological aspects of tissue renin-angiotensin system: emphasis on cardiovascular control. J Hypertens 1988;(Suppl. 6):S7–S12.

    Article  CAS  Google Scholar 

  17. Dzau VJ. Short and long term determinants of cardiovascular function and therapy: contributions of circulation and tissue renin-angiotensin systems. J Cardiovasc Pharmacol 1989;14:51–55.

    Google Scholar 

  18. Dzau VJ, Ingelfinger J, Pratt RE, Ellison KE. Identification of renin and angiotensinogen messenger RNA sequences in mouse and rat brains. Hypertension 1986;8:544–548.

    Article  PubMed  CAS  Google Scholar 

  19. Eggena P, Barrett JD, Fredal AM, Morin AM. Stimulation of brain and aortic renin substrate by central administration of steroids in the rat. J Hypertens 1987;(Suppl. 5):S11–S13.

    CAS  Google Scholar 

  20. Ganten D, Schelling P, Vescsei P, GantenU. Isorenin of extrarenal origin: “the tissue angiotensinogenase systems.” Am J Med 1976;60:760–772.

    Article  PubMed  CAS  Google Scholar 

  21. Eggena P, Willesey P, Jamgotchian N, Truckenbrod L, Hu MS, Barrett JD, Eggena MP, Clegg K, Nakoul F, Lee DBN. The influence of recombinant human erythropoietin on blood pressure and tissue renin angiotensin systems of the rat. Am J Physiol 1991;261:E642–E646.

    PubMed  CAS  Google Scholar 

  22. Paul M, Wagner J, Dzau V. Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by polymerase chain reaction. J Clin Invest 1993;91:2058–2064.

    Article  PubMed  CAS  Google Scholar 

  23. Yanagawa N, Capprelli AW, Jo OD, Friedal A, Barrett JD, Eggena P. Production of angiotensinogen and renin by renal proximal tubular cells. Kidney Intern 1991;39:938–941.

    Article  CAS  Google Scholar 

  24. Dzau VJ. Significance of the vascular renin-angiotensin pathway. Hypertension 1986;8:553–559.

    Article  PubMed  CAS  Google Scholar 

  25. Asaad MM, Antonaccio MS. Vascular wall renin in spontaneously hypertensive rats: potential relevance to hypertension maintenance and antihypertensive effect of captopril. Hypertension 1982;4:487–493.

    Article  PubMed  CAS  Google Scholar 

  26. Rosenthal JH, Pfeifle B, Michanilov ML, Pschoor J, Jacob ICM, Dahlheim H. Investigations of components of the renin angiotensin system in rat vascular tissue. Hypertension 1984;6:383–390.

    Article  PubMed  CAS  Google Scholar 

  27. Berka JL, Alcorn D, Ryan GB, Skinner SL, Weaver DA. Renin processing in cultured juxtaglomerular cells of the hydronephrotic mouse kidney. J Histochem Cytochem 1993;41:365–373.

    Article  PubMed  CAS  Google Scholar 

  28. Okumura A, Tanaka T, Mori H. Juxtaglomerular cell tumor cell line producing active renin and its precursors. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;64:303–307.

    Article  PubMed  CAS  Google Scholar 

  29. Gould LB, Skeggs LT, Kaha JR. Presence of renin activity in blood vessel walls. J Exp Med 1964;119:389,390.

    Article  Google Scholar 

  30. Barrett JD, Eggena P, Sambhi MP. A comparison of physical characteristics of renin isolated from aorta and plasma of the rat. In: Sambhi MP, ed. Heterogeneity of Renin and Renin Substrate. American Elsevier, New York, 1981, pp. 317–326.

    Google Scholar 

  31. Eggena P, Barrett JD, Sambhi MP, Fredal AM. Renin substrate and the renin-angiotensin system in hog tissues. Biochem Med Metab Biol 1986;36:82–90.

    Article  PubMed  CAS  Google Scholar 

  32. Swales JD, Samani NJ. Vascular RAA system. J Hum Hypertens 1993;7(Suppl. 2):S3–S6.

    PubMed  Google Scholar 

  33. Holycross BJ, Saye J, Harrison JK, Peach MJ. Polymerase chain reaction analysis of renin in rat aortic smooth muscle. Hypertension 1992;19:697–701.

    Article  PubMed  CAS  Google Scholar 

  34. Rothwell V, Kosowski S, Hadjilambris O, Baska R, Norman J. Glycosylation of active human renin is necessary for secretion: effect of targeted modifications of Asn-5 and Asn-75. DNA Cell Biol 1993;12:291–298.

    Article  PubMed  CAS  Google Scholar 

  35. Berka JL, Alcom D, Ryan GB, Skinner SL. Renin processing studied by immunogold localization of prorenin and renin in granular juxtaglomerular cells in mice treated with enalapril. Cell Tissue Res 1992;268:141–148.

    Article  PubMed  CAS  Google Scholar 

  36. Berka JL, Alcorn D, Coghlan JP, Fernley RT, Morgan TO, Ryan GB, Skinner SL, Weaver DA. Granular juxtaglomerular cells and prorenin synthesis in mice treated with enalapril. J Hypertens 1990;8:229–238.

    Article  PubMed  CAS  Google Scholar 

  37. Shinagawa T, Do YS, Baxter JD, Carilli C, Schilling J, Hsueh WA. Identification of an enzyme in human kidney that correctly processes prorenin. Proc Natl Acad Sci USA 1990;87:1927–1931.

    Article  PubMed  CAS  Google Scholar 

  38. Derkx FH, Deinum J, Lipovski M, Verhaar M, Fischli W, Schalekamp MA. Nonproteolytic “activation” of prorenin by active site-directed renin inhibitors as demonstrated by renin-specific monoclonal antibody. J Biol Chem 1992;267:22837–22842.

    PubMed  CAS  Google Scholar 

  39. Benjannet S, Reudelhuber T, Mercure C, Rondeau N, Chretien M, Seidah NG. Proprotein conversion is determined by a multiplicity of factors including convertase processing, substrate specificity, and intracellular environment. Cell type-specific processing of human prorenin by the convertase PC 1. J Biol Chem 1992;267:11417–11423.

    PubMed  CAS  Google Scholar 

  40. Iwai N, Matsunaga M, Kita T, Tei M, Kawai C. Regulation of renin-like enzyme in cultured human vascular smooth muscle cells. Jpn Circ J 1988;52:1338–1345.

    Article  PubMed  CAS  Google Scholar 

  41. Taddei S, Virdis A, Abdel-Haq B, Giovannetti R, Duranti P, Arena AM, Favilla S, Salvetti A Indirect evidence for vascular uptake of circulating renin in hypertensive patients. Hypertension 1993;21:852–860.

    Article  PubMed  CAS  Google Scholar 

  42. Danser AH, Admiraal PJ, Derkx FH, Lamers JM, Verdouw PD, Saxena PR, Schalekamp MA. Cardiac renin is kidney-derived. J Hypertens 1993;(Suppl.5):S224–S225.

    Google Scholar 

  43. Hilgers KF, Mann JFL. Tissue renin: focus on vascular angiotensin formation. Arzneimittel-Forschung 1993;43:198–201.

    PubMed  CAS  Google Scholar 

  44. Campbell DJ, Valentij in AJ. Identification of vascular renin-binding proteins by chemical cross-linking: inhibition of binding of renin by renin inhibitors. J Hypertens 1994;12:879–890.

    Article  PubMed  CAS  Google Scholar 

  45. Müller D, Hilgers KF, Bohlender J, Lippoldt A, Wagner J, Fischli W, Ganten D, Mann JFE, Luft FC. Effect of human renin in the vasculature of rats transgenic for human angiotensinogen. Hypertension 1995;26:272–278.

    Article  PubMed  Google Scholar 

  46. Eggena P, Krall JF, Eggena MP, Clegg K, Fittigoff M, Barrett JD. Production of angiotensinogen in rat aortic smooth muscle cells. Clin Exp Hypertens 1990;Al2:1175–1189.

    Article  Google Scholar 

  47. Kifor I, Dzau VJ. Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circ Res 1987;60:422–428.

    Article  PubMed  CAS  Google Scholar 

  48. Rakugi H, Jacob HJ, Krieger JE, Ingelfinger Jr, Pratt RE. Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation 1993;87:283–290.

    Article  PubMed  CAS  Google Scholar 

  49. Frederich PC Jr, Kahn BB, Peach MJ, Flier JS. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992;19:339–344.

    Article  PubMed  CAS  Google Scholar 

  50. Naftilan AJ, Zuo WM, Ingelfinger J, Ryan TJ Jr, Pratt RE, Dzau VJ. Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall. J Clin Invest 1991;87: 1300–1331.

    Article  PubMed  CAS  Google Scholar 

  51. Sernia C, Shinkel TA, Thomas WG, Ho KK, Lincoln D. Angiotensinogen secretion by single rat pituitary cells: detection by a reverse haemolytic plaque assay and cell identification by immunocytochemistry. Neuroendocrin 1992;55:308–316.

    Article  CAS  Google Scholar 

  52. Unger T, Gohlke P, Paul M, Rettig R. Tissue renin-angiotensin systems: fact or fiction? J Cardiovasc Pharmacol 1992;2(Suppl. 18):S20–S25.

    Google Scholar 

  53. Fishel RS, Eisenberg S, Shai SY, Redden RA, Bernstein KE, Berk BC. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension 1995;25:343–349.

    Article  PubMed  CAS  Google Scholar 

  54. Ideishi M, Noda K, Sasaguri M, Ikeda M, Arakawa K. Angiotensin II forming activity of vascular endothelial and smooth muscle cells. Artery 1993;20:95–102.

    PubMed  CAS  Google Scholar 

  55. Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Menard J. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation 1995;92:825–834.

    Article  PubMed  CAS  Google Scholar 

  56. Boucher R, Asselin J, Genest J. A new enzyme leading to the direct formation of angiotensin II. Circ Res 1974;34/35(Suppl. I):I203–I212.

    Google Scholar 

  57. Urata H, Hoffmann S, Ganten D. Tissue angiotensin II system in the human heart. Eur Heart J 1994; Suppl. D:68–78.

    Article  Google Scholar 

  58. Drummer OH, Kourtis S, Johnson H. Effect of chronic enalapril treatment on enzymes responsible for the catabolism of angiotensin I and formation of angiotensin II. Biochem Pharmacol 1990;39:513–518.

    Article  PubMed  CAS  Google Scholar 

  59. Campbell DJ, Ziogas J, Kladis A. Metabolism of tetradecapeptide, angiotensinogen and angiotensin I and II by isolated perfused rat hindlimbs. Clin Exp Pharmacol Physiol 1990;17:335–350.

    Article  PubMed  CAS  Google Scholar 

  60. Sandberg K, Ji H, Catt KJ. Regulation of angiotensin II receptors in rat brain during dietary sodium changes. Hypertension 1994;23(Suppl. 1):I137–I141.

    Article  PubMed  CAS  Google Scholar 

  61. Campbell DJ, Kladis A, Skinner SL, Whitworth JA. Characterization of angiotensin peptides in plasma of anephric man. J Hypertens 1991;9:265–274.

    Article  PubMed  CAS  Google Scholar 

  62. Eggena P, Barrett JD, Shionoiri H, Sambhi MP. Enzymatic studies with renin substrate. In: Villarreal H, Sambhi P, eds. Topics in Pathophysiology of Hypertension. Martinus Nijhoff, Boston, MA, 1984, pp. 430–439.

    Chapter  Google Scholar 

  63. Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H, Schalekamp MADH. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 1990;15:44–55.

    Article  PubMed  CAS  Google Scholar 

  64. Danser AH, Koning MM, Admiraal PJ, Sassen LM, Derkx FH, Verdouw PD, Schalekamp MA. Production of angiotensins I and II at tissue sites in intact pigs. Am J Physiol 1992;263:H429–H437.

    PubMed  CAS  Google Scholar 

  65. Yu H, Rakugi H, Higaki J, Morishita R, Mikami H, Ogihara T. The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney one clip hypertensive rats. J Hypertens 1993;11:1347–1355.

    Article  PubMed  CAS  Google Scholar 

  66. Oddie CJ, Dilley RJ, Kanellakis P, Bobik A. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity. J Hypertens 1993;11:717–724.

    Article  PubMed  CAS  Google Scholar 

  67. Kiowski W, Linder L, Kleinbloesem C, van Brummelen P, Buhler FR. Blood pressure control by the renin angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition. Circulation 1992;85:1–8.

    Article  PubMed  CAS  Google Scholar 

  68. Linz W, Schoelkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and induces the regression of cardiac hypertrophy in rats. Clin Exp Hypertens 1989;A11:1325–1350.

    Article  Google Scholar 

  69. Sneedden W, Femandex PG, Femandex D, Vasdev S, Rabin EZ. Correlation of left ventricular hypertrophy and its regression by lisinopril with salt-induced hypertension. Can J Cardiol 1988;4:237–242.

    Google Scholar 

  70. Gyurko R, Wielbo D, Phillips MI. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Reg Peptides 1993;49: 167–174.

    Article  CAS  Google Scholar 

  71. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990;344:541–544.

    Article  PubMed  CAS  Google Scholar 

  72. Dzau VJ. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. Bas Res Cardiol 1993;88:(Suppl. 1):1–14.

    CAS  Google Scholar 

  73. Paul M, Ganten D. The molecular basis of cardiovascular hypertrophy: the role of the renin-angiotensin system. J Cardiovasc Pharmacol 1992;19(Suppl. 5):S51–S58.

    PubMed  CAS  Google Scholar 

  74. Bianchi C, Gutkowska J, De Lean A, Ballak M, Anand-Srivastava MB, Genest J, Cantin M. Fate of (125I) angiotensin II in adrenal glomerulosa cells. Endocrinology 1986;118:2605–2607.

    Article  PubMed  CAS  Google Scholar 

  75. Eggena P, Zhu JH, Clegg K, Barrett JD. Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension 1993;22:496–501.

    Article  PubMed  CAS  Google Scholar 

  76. Re RN, Vizard DL, Brown J, Bryan SE. Angiotensin II receptors in chromatin fragments generated by micrococcal nuclease. Biochem Biophys Res Comm 1984;119:220–227.

    Article  PubMed  CAS  Google Scholar 

  77. Re R, Parab M. Effect of angiotensin II on RNA synthesis by isolated nuclei. Life Sci 1984;34:647–651.

    Article  PubMed  CAS  Google Scholar 

  78. Klett C, Hellmann W, Ganten D, Hackenthal E. Tissue distribution of angiotensinogen mRNA during experimental inflammation. Inflammation 1993;17:183–197.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Eggena, P., Barrett, J.D. (1996). The Vascular Renin System. In: Sowers, J.R. (eds) Endocrinology of the Vasculature. Contemporary Endocrinology, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0231-8_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-0231-8_15

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4612-6672-3

  • Online ISBN: 978-1-4612-0231-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics